Your browser doesn't support javascript.
loading
Baseline QRS duration associates with cardiac recovery in patients with continuous-flow left ventricular assist device implantation.
Khan, Muhammad S; Kyriakopoulos, Christos P; Taleb, Iosif; Dranow, Elizabeth; Scott, Monte; Ranjan, Ravi; Yin, Michael; Tseliou, Eleni; Alharethi, Rami; Caine, William; Shaw, Robin M; Selzman, Craig H; Drakos, Stavros G; Dosdall, Derek J.
  • Khan MS; Nora Eccles Harrison Cardiovascular Research and Training Institute, The University of Utah, Salt Lake City, UT, United States of America.
  • Kyriakopoulos CP; Nora Eccles Harrison Cardiovascular Research and Training Institute, The University of Utah, Salt Lake City, UT, United States of America.
  • Taleb I; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah Health & School of Medicine, Salt Lake City, UT, United States of America.
  • Dranow E; Nora Eccles Harrison Cardiovascular Research and Training Institute, The University of Utah, Salt Lake City, UT, United States of America.
  • Scott M; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah Health & School of Medicine, Salt Lake City, UT, United States of America.
  • Ranjan R; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah Health & School of Medicine, Salt Lake City, UT, United States of America.
  • Yin M; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah Health & School of Medicine, Salt Lake City, UT, United States of America.
  • Tseliou E; Nora Eccles Harrison Cardiovascular Research and Training Institute, The University of Utah, Salt Lake City, UT, United States of America.
  • Alharethi R; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah Health & School of Medicine, Salt Lake City, UT, United States of America.
  • Caine W; Department of Biomedical Engineering, The University of Utah, Salt Lake City, UT, United States of America.
  • Shaw RM; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah Health & School of Medicine, Salt Lake City, UT, United States of America.
  • Selzman CH; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah Health & School of Medicine, Salt Lake City, UT, United States of America.
  • Drakos SG; Cardiovascular Department, Intermountain Medical Center, Salt Lake City, UT, United States of America.
  • Dosdall DJ; Cardiovascular Department, Intermountain Medical Center, Salt Lake City, UT, United States of America.
Am Heart J Plus ; 22: 100211, 2022 Oct.
Article en En | MEDLINE | ID: mdl-38558900
ABSTRACT

Objective:

In chronic heart failure (HF) patients supported with continuous-flow left ventricular assist device (CF-LVAD), we aimed to assess the clinical association of pre-LVAD QRS duration (QRSd) with post-LVAD cardiac recovery, and its correlation with pre- to post-LVAD change in left ventricular ejection fraction (LVEF) and left ventricular end-diastolic diameter (LVEDD).

Methods:

Chronic HF patients (n = 402) undergoing CF-LVAD implantation were prospectively enrolled, at one of the centers comprising the U.T.A.H. (Utah Transplant Affiliated Hospitals) consortium. After excluding patients with acute HF etiologies, hypertrophic or infiltrative cardiomyopathy, and/or inadequate post-LVAD follow up (<3 months), 315 patients were included in the study. Cardiac recovery was defined as LVEF ≥ 40 % and LVEDD < 6 cm within 12 months post-LVAD implantation. Patients fulfilling this condition were termed as responders (R) and results were compared with non-responders (NR).

Results:

Thirty-five patients (11 %) achieved 'R' criteria, and exhibited a 15 % shorter QRSd compared to 'NR' (123 ± 37 ms vs 145 ± 36 ms; p < 0.001). A univariate analysis identified association of baseline QRSd with post-LVAD cardiac recovery (OR 0.986, 95 % CI 0.976-0.996, p < 0.001). In a multivariate logistic regression model, after adjusting for duration of HF (OR 0.990, 95 % CI 0.983-0.997, p = 0.006) and gender (OR 0.388, 95 % CI 0.160-0.943, p = 0.037), pre-LVAD QRSd exhibited a significant association with post-LVAD cardiac structural and functional improvement (OR 0.987, 95 % CI 0.977-0.998, p = 0.027) and the predictive model showed a c-statistic of 0.73 with p < 0.001. The correlations for baseline QRSd with pre- to post-LVAD change in LVEF and LVEDD were also investigated in 'R' and 'NR' groups.

Conclusion:

Chronic advanced HF patients with a shorter baseline QRSd exhibit an increased potential for cardiac recovery after LVAD support.
Palabras clave